Related Experiment Videos
Neonatal hypocalcemia mechanism of occurrence and management
Insights
Neonatal hypocalcemia, a calcium deficiency, affects premature and asphyxiated infants. Causes range from low calcium supply to vitamin D issues, with treatment involving calcium salts and new vitamin D metabolites.
Area of Science:
- Neonatology
- Pediatric Endocrinology
- Biochemistry
Background:
- Neonatal hypocalcemia is a common electrolyte disturbance in newborns.
- It presents as early or late-onset hypocalcemia, affecting specific infant populations.
- Several etiological factors contribute to its development.
Purpose of the Study:
- To review the causes and therapeutic strategies for neonatal hypocalcemia.
- To provide a comprehensive overview of early and late-onset hypocalcemia.
- To discuss current and emerging treatment options.
Main Methods:
- Literature review of neonatal hypocalcemia.
- Analysis of etiological factors for early and late-onset hypocalcemia.
- Summary of therapeutic interventions.
Main Results:
- Early neonatal hypocalcemia is linked to prematurity, birth asphyxia, and diabetic mothers.
- Late neonatal hypocalcemia is associated with malabsorption, phosphate loading, and vitamin D disorders.
- Therapies include calcium salts and potentially new vitamin D metabolites.
Conclusions:
- Understanding the diverse causes of neonatal hypocalcemia is crucial for timely diagnosis.
- Effective management involves addressing underlying etiological factors.
- Advancements in vitamin D metabolism offer promising future therapeutic avenues.
Abstract:
Early neonatal hypocalcemia occurs in premature infants, infants with birth asphyxia, and infants of diabetic mothers. Etiological considerations include decreased calcium (Ca) supply, increased endogenous phosphate load, hypomagnesemia, alkali therapy, functional hypoparathyroidism, defects in vitamin D metabolism, and possibly calcitonin excess. Late neonatal hypocalcemia occurs, with malabsorption of magnesium (Mg), increased exogenous phosphate loading, after alkali therapy of diarrheal acidosis, hypoparathyroidism, and vitamin D related disorders. The therapy of hypocalcemia includes oral or iv Ca salts and in the near future, possibly the newly discovered vitamin D metabolites.